DJIA 16,262.56 89.32 0.55%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 12.37 0.68%
market minute promo



company name or ticker

3 Technology Sector Picks for 2011

Cephalon's Foray Into Stem Cells Therapeutic Market

China Analyst: 10 Pharma Stocks With Highest Growth Potential

Stem Cell Confusion Creates Opportunity in These Four Names

Court Decision Puts Pressure on Embryonic Stem Cell Stocks

Global Factors Boosting Biotech Today

CNBC on StemCells, Inc.

At the end of the day they know if they don't step up to the plate and buy these the end consumer in the united states, which is the global spender, is going to end up being weaker than what they want. Attend of the day, the STEM louse and the recovery of china and the rest of the world is to really bail us out and the way they bail us out is to buy our treasuries. >> john, by any measure a subpar recovery as far as recoveries are concerned, but it seems that the market, as long as it can get it

Stem cell transplants stalled blindness in rats